TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00198380 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00198380 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00212108 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03161002 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01414621 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03095742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02080715 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01306045 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01306045 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01306045 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT01306045 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01306045 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01306045 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01306045 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT01306045 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01306045 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02736695 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02011906 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT02011906 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT02011906 — Predictive Biomarker (PRD): FOXO1 mRNA
Genes: FOXO1; FKHR; FOXO1A
Study NCT02011906 — Predictive Biomarker (PRD): SIRT3 mRNA
Genes: SIRT3; SIR2L3
Study NCT02011906 — Predictive Biomarker (PRD): SIRT6 mRNA
Genes: SIRT6; SIR2L6
Study NCT02246231 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT05153616 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04906564 — Predictive Biomarker (PRD): RNF213 mRNA
Genes: RNF213; ALO17; C17orf27; KIAA1554; KIAA1618; MYSTR
Study NCT03401619 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05716802 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04794777 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03868592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03023111 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00432172 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00003362 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03551223 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02229500 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00976352 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT04064931 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00668902 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04851470 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT00002560 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04583384 — Predictive Biomarker (PRD): SRM mRNA
Genes: SRM; SPS1; SRML1
Study NCT03979339 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02233686 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT01752335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04551547 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01826279 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04585464 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT04201262 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT03459755 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT04461327 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT01766622 — Predictive Biomarker (PRD): DIABLO mRNA
Genes: DIABLO; SMAC
Study NCT00944047 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01759810 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04502251 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04502251 — Safety Biomarker (SAF): BDNF
Study NCT03119623 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00616980 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01106170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00518154 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02785250 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT03168880 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03168880 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03168880 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03168880 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT03168880 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03168880 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01324258 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02696525 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04496505 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04496505 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT01264666 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02197624 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT00976222 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06330389 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02912572 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT01923597 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00059878 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03872622 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT02367781 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02980029 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study NCT00143312 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT06648044 — Predictive Biomarker (PRD): NPHP1 mRNA
Genes: NPHP1; NPH1
Study NCT06648044 — Predictive Biomarker (PRD): NPHP4 mRNA
Genes: NPHP4; KIAA0673
Study NCT04211922 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02085967 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT01082016 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04123782 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04123782 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03745326 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03745326 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03390946 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03021785 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02656134 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04616131 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01735968 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00317200 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00282334 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03666832 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT03666832 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03666832 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03666832 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03666832 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03666832 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04175782 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04011904 — Predictive Biomarker (PRD): TBC1D4 mRNA
Genes: TBC1D4; AS160; KIAA0603
Study NCT00491699 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00491699 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02441543 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02404935 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02404935 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02826642 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT01803984 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03930719 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study NCT00001611 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04572477 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01250132 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT01328548 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01149421 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02718183 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT02487615 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02487615 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT02487615 — Predictive Biomarker (PRD): PLA2G7 mRNA
Genes: PLA2G7; PAFAH
Study NCT02487615 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT02487615 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00828776 — Predictive Biomarker (PRD): TTPA mRNA
Genes: TTPA; TPP1
Study NCT00997100 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT00336973 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01590719 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00157040 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02273271 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT00135668 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02163174 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03493230 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03493230 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03493230 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01074502 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01534026 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00520182 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT03301311 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02317926 — Predictive Biomarker (PRD): DIO2 mRNA
Genes: DIO2; ITDI2; TXDI2
Study NCT02650050 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03223545 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02946138 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01356082 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03278470 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02186470 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03829540 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00772590 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00026143 — Safety Biomarker (SAF): Interleukin 12
Study NCT00551252 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03149679 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03149679 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03778879 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT00551798 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00551798 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT00551798 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study NCT00572468 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04589741 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT00558064 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03146923 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04141670 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study NCT01714687 — Predictive Biomarker (PRD): RARS1 mRNA
Genes: RARS1; RARS
Study NCT02235051 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT02235051 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02966756 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT02989064 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03448250 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03448250 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00629668 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04174469 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00776243 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02614001 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01708356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02621450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03207295 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06538428 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06538428 — Predictive Biomarker (PRD): NUPR1 mRNA
Genes: NUPR1; COM1
Study NCT06538428 — Predictive Biomarker (PRD): NDRG2 mRNA
Genes: NDRG2; KIAA1248; SYLD
Study NCT06538428 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study NCT03228550 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03182335 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01459211 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03022552 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT01128634 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01128634 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT04554160 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02955615 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00043316 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01901107 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03435250 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT02660814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04066192 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study NCT02241616 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02601846 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04640337 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT01342861 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00876109 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT00524225 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT00524225 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01653288 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT03515889 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02279745 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04561102 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00897663 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00897663 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02539472 — Predictive Biomarker (PRD): KIR2DL4 mRNA
Genes: KIR2DL4; CD158D; KIR103AS
Study NCT02539472 — Predictive Biomarker (PRD): PLS3 mRNA
Genes: PLS3
Study NCT02539472 — Predictive Biomarker (PRD): TOX mRNA
Genes: TOX; KIAA0808
Study NCT02539472 — Predictive Biomarker (PRD): KIR3DL1 mRNA
Genes: KIR3DL1; CD158E; NKAT3; NKB1
Study NCT01072318 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04349865 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT02946918 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04225988 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02628990 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT03588078 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00001788 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT00001788 — Predictive Biomarker (PRD): STAT4 mRNA
Genes: STAT4
Study NCT00001788 — Safety Biomarker (SAF): Interleukin 12
Study NCT01388673 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02807480 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00489333 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03022318 — Predictive Biomarker (PRD): GPR143 mRNA
Genes: GPR143; OA1
Study NCT03022318 — Predictive Biomarker (PRD): SERPINF1 mRNA
Genes: SERPINF1; PEDF; PIG35
Study NCT03022318 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01151189 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03233659 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02487979 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT04529902 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02726854 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03113500 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04049786 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04620187 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02172625 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00799643 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03040492 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT01721252 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01524575 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT02034890 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01692964 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT03024489 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03024489 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT03024489 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT01530932 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02235415 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00091247 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00091247 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04486768 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT03792529 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03792529 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04006262 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04006262 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04006262 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03786692 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03786692 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03786692 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01601028 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT01394042 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02552394 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27